A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week
Why Cochrane collaboration makes strongest researchers
So what has the Cochrane membership done for me? Inspired by Dr Jeremy Grimshaw’s question: “So what has the Cochrane Collaboration ever done for us?”
Missing Evidence on Addiction Medicine Professional Training Needs
We wanted to find out whether newly trained professionals working in addiction medicine around the world felt they had enough and appropriate training
How to find non-academic mentors
Mentors facilitate professional development in academia. But non-academic mentors are equally important. Here, I acknowledge non-academic mentors and
Addiction training provision must meet training needs
Closing the gap between training needs and training provision in addiction medicine Substance use disorders pose a significant
Hospital based opioid agonist treatment
Researchers recently found that many people with co-occurring mental health and substance use disorders are admitted to inpatient psychiatric units.
Pain Management with Opioids in 2019-2020
This JAMA Insights Clinical Update reviews evidence-based use of opioids to manage noncancer pain, proposing opioid-sparing pain management. Based on
Boost for Oral Opioid Agonist Therapy
Although opioid agonist treatment is effective in treating opioid use disorders, retention in such treatment is suboptimal in part due to quality of
America could relax opioid treatment access policies
Canada and the United States (U.S.) face an opioid use disorder and opioid overdose epidemic. The most effective OUD treatment is opioid agonist